These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 25572695)

  • 1. Anti-proliferative effects of polyphenols from pomegranate rind (Punica granatum L.) on EJ bladder cancer cells via regulation of p53/miR-34a axis.
    Zhou B; Yi H; Tan J; Wu Y; Liu G; Qiu Z
    Phytother Res; 2015 Mar; 29(3):415-22. PubMed ID: 25572695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myc overexpression brings out unexpected antiapoptotic effects of miR-34a.
    Sotillo E; Laver T; Mellert H; Schelter JM; Cleary MA; McMahon S; Thomas-Tikhonenko A
    Oncogene; 2011 Jun; 30(22):2587-94. PubMed ID: 21297663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The DNA methylation-regulated miR-193a-3p dictates the multi-chemoresistance of bladder cancer via repression of SRSF2/PLAU/HIC2 expression.
    Lv L; Deng H; Li Y; Zhang C; Liu X; Liu Q; Zhang D; Wang L; Pu Y; Zhang H; He Y; Wang Y; Yu Y; Yu T; Zhu J
    Cell Death Dis; 2014 Sep; 5(9):e1402. PubMed ID: 25188512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enzymatic Spermine Metabolites Induce Apoptosis Associated with Increase of p53, caspase-3 and miR-34a in Both Neuroblastoma Cells, SJNKP and the N-Myc-Amplified Form IMR5.
    Kanamori Y; Finotti A; Di Magno L; Canettieri G; Tahara T; Timeus F; Greco A; Tirassa P; Gasparello J; Fino P; Di Liegro CM; Proia P; Schiera G; Di Liegro I; Gambari R; Agostinelli E
    Cells; 2021 Jul; 10(8):. PubMed ID: 34440719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD95 is part of a let-7/p53/miR-34 regulatory network.
    Hau A; Ceppi P; Peter ME
    PLoS One; 2012; 7(11):e49636. PubMed ID: 23166734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of miR-34a on the expression of clock and clock-controlled genes in DLD1 and Lovo human cancer cells with different backgrounds with respect to p53 functionality and 17β-estradiol-mediated regulation.
    Moravčík R; Olejárová S; Zlacká J; Herichová I
    PLoS One; 2023; 18(10):e0292880. PubMed ID: 37831728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salicylate induces AMPK and inhibits c-MYC to activate a NRF2/ARE/miR-34a/b/c cascade resulting in suppression of colorectal cancer metastasis.
    Liu C; Rokavec M; Huang Z; Hermeking H
    Cell Death Dis; 2023 Oct; 14(10):707. PubMed ID: 37898661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A rationalized definition of general tumor suppressor microRNAs excludes miR-34a.
    Mockly S; Houbron É; Seitz H
    Nucleic Acids Res; 2022 May; 50(8):4703-4712. PubMed ID: 35474387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic Action of 1,2-Epoxy-3 (3- (3,4-dimethoxyphenyl)- 4H-1-benzopiyran-4-on) Propane with Doxorubicin and Cisplatin through Increasing of p53, TIMP-3, and MicroRNA-34a in Cervical Cancer Cell Line (HeLa).
    Yuniarti L; Mustofa M; Aryandono T; Haryana SM
    Asian Pac J Cancer Prev; 2018 Oct; 19(10):2955-2962. PubMed ID: 30362332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-34a is a tumor suppressor in zebrafish and its expression levels impact metabolism, hematopoiesis and DNA damage.
    Prykhozhij SV; Ban K; Brown ZL; Kobar K; Wajnberg G; Fuller C; Chacko S; Lacroix J; Crapoulet N; Midgen C; Shlien A; Malkin D; Berman JN
    PLoS Genet; 2024 May; 20(5):e1011290. PubMed ID: 38805544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A first-in-class fully modified version of miR-34a with outstanding stability, activity, and anti-tumor efficacy.
    Abdelaal AM; Sohal IS; Iyer S; Sudarshan K; Kothandaraman H; Lanman NA; Low PS; Kasinski AL
    Oncogene; 2023 Sep; 42(40):2985-2999. PubMed ID: 37666938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MYC Causes Multiple Myeloma Progression via Attenuating TP53-Induced MicroRNA-34 Expression.
    Murakami Y; Kimura-Masuda K; Oda T; Matsumura I; Masuda Y; Ishihara R; Watanabe S; Kuroda Y; Kasamatsu T; Gotoh N; Takei H; Kobayashi N; Saitoh T; Murakami H; Handa H
    Genes (Basel); 2022 Dec; 14(1):. PubMed ID: 36672841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of tumor suppressor p53 and micro-RNA interplay in multiple myeloma pathogenesis.
    Abdi J; Rastgoo N; Li L; Chen W; Chang H
    J Hematol Oncol; 2017 Oct; 10(1):169. PubMed ID: 29073933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The tumor suppressor p53 can promote collective cellular migration.
    He S; Carman CV; Lee JH; Lan B; Koehler S; Atia L; Park CY; Kim JH; Mitchel JA; Park JA; Butler JP; Lu Q; Fredberg JJ
    PLoS One; 2019; 14(2):e0202065. PubMed ID: 30707705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthetic miR-34a against solid tumours: a predictable failure.
    Mockly S; Seitz H
    Br J Cancer; 2023 Feb; 128(3):478-480. PubMed ID: 36550206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ellagic acid induces cell cycle arrest and apoptosis through TGF-β/Smad3 signaling pathway in human breast cancer MCF-7 cells.
    Chen HS; Bai MH; Zhang T; Li GD; Liu M
    Int J Oncol; 2015 Apr; 46(4):1730-8. PubMed ID: 25647396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential Effects of Pomegranate Polyphenols in Cancer Prevention and Therapy.
    Turrini E; Ferruzzi L; Fimognari C
    Oxid Med Cell Longev; 2015; 2015():938475. PubMed ID: 26180600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of pomegranate medicinal products for cancer.
    Vlachojannis C; Zimmermann BF; Chrubasik-Hausmann S
    Evid Based Complement Alternat Med; 2015; 2015():258598. PubMed ID: 25815026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanoencapsulation of pomegranate bioactive compounds for breast cancer chemoprevention.
    Shirode AB; Bharali DJ; Nallanthighal S; Coon JK; Mousa SA; Reliene R
    Int J Nanomedicine; 2015; 10():475-84. PubMed ID: 25624761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Pomegranate Juice on Hormonal Biomarkers of Breast Cancer Risk.
    Kapoor R; Ronnenberg A; Puleo E; Chatterton RT; Dorgan JF; Seeram NP; Sturgeon SR
    Nutr Cancer; 2015; 67(7):1113-9. PubMed ID: 26327495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.